Interferon-α of variable value in melanoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1599, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Point: Interferon-α for Adjuvant Therapy for Melanoma Patients

By Sabel Michael S. Sondak Vernon K.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 1, 2004-01 ,pp. : 61-68

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Cost-effectiveness of interferon-α₂ as adjuvant therapy in malignant melanoma

By Lafuma Antoine Grob Jean Jacques

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 343-349

Informa Healthcare

Access to resources Recommend Favorite

Interferon-α-2b: Primary cutaneous malignant melanoma (first report) in patients with malignant melanoma: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1260, 2009-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite

Interferon-α: Delayed sarcoidosis

Reactions Weekly, Vol. 1, Iss. 1049, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Counterpoint: The Case Against Adjuvant High-Dose Interferon-α for Melanoma Patients

By Chapman Paul B.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 1, 2004-01 ,pp. : 69-72

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite